Skip to main content

Smith Scott Andrew's Form 4 filing

BioAtla, Inc. (BCAB) · filed Dec 7, 2021

Accession no.
0001209191-21-068385
Filed
Dec 7, 2021
Trade date
Nov 30-Dec 2, 2021
Filing delay
7 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market sales total $91.1K. It was filed 7 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Smith Scott AndrewCIK 0001614975Director, Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 30, 2021Common StockSSaleDisposed−194$24.00−$4,656349,552Direct
Nov 30, 2021Common StockSSaleDisposed−210$24.68−$5,182.8349,342Direct
Nov 30, 2021Common StockSSaleDisposed−74$25.38−$1,878.12349,268Direct
Dec 1, 2021Common StockSSaleDisposed−202$22.19−$4,482.38349,066Direct
Dec 1, 2021Common StockSSaleDisposed−350$23.27−$8,144.5348,716Direct
Dec 1, 2021Common StockSSaleDisposed−76$24.22−$1,840.72348,640Direct
Dec 2, 2021Common StockSSaleDisposed−2,925$21.74−$63,589.5345,715Direct
Dec 2, 2021Common StockSSaleDisposed−59$22.47−$1,325.73345,656Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)